The purpose of this study is to evaluate the long term safety and tolerability of CDP6038 treatment in adult subjects with active rheumatoid arthritis (RA) who completed RA0056.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01296711?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
